Search Results 6361-6370 of 38180 for oral
A total of 159 patients will be randomized 2:1 to treatment with oral pomalidomide or matching placebo for 24 weeks. Mean change from baseline to 24 weeks ...
... oral hypoglycemics), Byetta or a sulfonylurea agent in the past three months; HbA1c greater than 9.0%; Have not been stable on all medications for a period ...
... oral contraception, IUD, or use of condoms or diaphragms); Signed informed consent. Exclusion Criteria. Evidence of residual disease after surgery and SoC ...
This medicine will not prevent HIV infection or other sexually transmitted diseases. It will not help as emergency contraception, such as after unprotected ...
Efgartigimod alfa-fcab injection is used to treat a nerve and muscle problem called myasthenia gravis in patients who are anti-acetylcholine receptor (AChR) ...
Taking oral medicine would break the fast. "This is something that needs to be discussed with your doctor or primary care provider to see if there are ways ...
Second place for the best oral presentation, University Medical Cluster Academic day, National University Hospital Singapore titled “Fluid resuscitation for ...
... oral cavity, oropharynx (p16 negative), hypopharynx, or supraglottic larynx * Stage III, IVA or IVB according to the 8th Edition of the American Joint ...
New CT imaging oral contrast agent improves visualization of bowel anatomy, clinical trial data show. ROCHESTER, Minn. — In a new pilot feasibility study, ...
Investigating tumor growth factors for oral cancer. Evaluating new methods of use for chemotherapy. Evaluating new radiation therapy regimens. Investigating the ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!